Industry Research Reports
Global Artemisunate Market Insights, Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-06-04
Pages: 165 Pages
Report ld: 4751196
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Artemisunate market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
Artemisunate is an antimalarial drug derived from artemisinin. It is characterized by high efficiency, low toxicity, and rapid action, making it one of the preferred drugs for treating malaria. Artemisunate works by disrupting the biological membrane structure of Plasmodium parasites, inhibiting their growth and reproduction, and thus achieving the goal of treating malaria. Due to its favorable pharmacokinetic properties and high bioavailability, artemisunate holds significant application value in the field of malaria prevention and control. Moreover, with the advancement of global malaria prevention and control efforts, the market demand for artemisunate is also increasing, driving the development of related industries.
Market Development Opportunities & Main Driving Factors
The market development opportunities and main driving factors of artemisunate are mainly reflected in three aspects. First, the continuous growth of global malaria prevention and control needs provides a broad space for the artemisunate market. Malaria is still relatively common in regions such as Africa and Asia. International organizations like the World Health Organization are constantly promoting malaria prevention and control work and increasing the procurement and distribution of antimalarial drugs, which leads to the increasing market demand for artemisunate. Secondly, the advantages of artemisunate itself also promote market development. It is characterized by high efficiency and rapid onset of action. Compared with traditional antimalarial drugs, it can more quickly relieve symptoms and reduce mortality in the treatment of malaria, so it is favored in clinical applications. In addition, with the continuous progress of pharmaceutical R & D technology, the production process of artemisunate is continuously optimized, and the production cost is gradually reduced, which helps to improve its market competitiveness and further expand its market share.
Market Challenges, Risks, & Restraints
The artemisunate market also faces some challenges and risks. On the one hand, the problem of drug resistance of Plasmodium is becoming more and more prominent, which poses a potential threat to the therapeutic effect of artemisunate. When Plasmodium develops resistance to artemisunate, it will lead to a decline in drug efficacy, and it is necessary to develop new drugs or combination therapy to deal with it. On the other hand, market competition is fierce. With the continuous expansion of the antimalarial drug market, more and more enterprises enter this field, and market competition intensifies. Enterprises need to continuously improve their competitiveness in product quality, price, sales channels and other aspects in order to occupy a place in the market. In addition, the stability of raw material supply also poses risks. The production of artemisunate depends on raw materials such as artemisinin, and the output of artemisinin is greatly affected by natural environment, planting area and other factors. The instability of raw material supply may lead to production interruption or cost increase.
Downstream Demand Trends
Looking at the downstream demand trends, the application fields of artemisunate will continue to expand. In the medical field, with the increasing attention to malaria prevention and control, the demand for antimalarial drugs in medical institutions will continue to increase. At the same time, with the development of medical technology, the application of artemisunate in malaria treatment will be more precise and personalized. In addition to the medical field, artemisunate also has important applications in the field of public health. Governments and international organizations will continue to increase investment in malaria prevention and control and purchase more artemisunate for prevention and control work in malaria - prone areas. In addition, with the acceleration of the globalization process, the more frequent personnel flow also increases the risk of malaria transmission, which will further promote the market demand for artemisunate.
In terms of production side, this report researches the Artemisunate production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Artemisunate by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Artemisunate, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Artemisunate, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Artemisunate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artemisunate sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Artemisunate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Artemisunate sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Ltd, CAT KHANH, BIONEXX, etc.
MARKET SEGMENTATION
By Company
- Sanofi
- KPC Pharmaceuticals
- Guangxi Xiancaotang Pharmaceutical
- Guilin Pharmaceutical
- Kerui Nanhai Pharmaceutical
- Shanghai Natural Bio-engineering Co
- Novanat Bioresource
- Botanical Extracts EPZ Ltd
- CAT KHANH
- BIONEXX
- Botanical Extracts EPZ
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pharmaceutical Grade
- Industrial Grade
Segment by Application
- Malaria Treatment
- Scientific Research
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Artemisunate production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Artemisunate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Artemisunate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artemisunate sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Artemisunate Product Introduction
1.2 Market by Type
1.2.1 Global Artemisunate Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Market by Application
1.3.1 Global Artemisunate Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Malaria Treatment
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Artemisunate Production
2.1 Global Artemisunate Production Capacity (2020-2031)
2.2 Global Artemisunate Production by Region: 2020 VS 2024 VS 2031
2.3 Global Production by Region
2.3.1 Global Artemisunate Production by Region (2020-2031)
2.3.2 Global Artemisunate Production Market Share by Region (2020-2031)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Artemisunate Revenue Estimates and Forecasts 2020-2031
3.2 Global Revenue by Region
3.2.1 Global Artemisunate Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Artemisunate Revenue by Region (2020-2031)
3.2.3 Global Artemisunate Revenue Market Share by Region (2020-2031)
3.3 Global Artemisunate Sales Estimates and Forecasts 2020-2031
3.4 Global Sales by Region
3.4.1 Global Artemisunate Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Artemisunate Sales by Region (2020-2031)
3.4.3 Global Artemisunate Sales Market Share by Region (2020-2031)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Sales by Manufacturers
4.1.1 Global Artemisunate Sales by Manufacturers (2020-2025)
4.1.2 Global Artemisunate Sales Market Share by Manufacturers (2020-2025)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artemisunate in 2024
4.2 Global Revenue by Manufacturers
4.2.1 Global Artemisunate Revenue by Manufacturers (2020-2025)
4.2.2 Global Artemisunate Revenue Market Share by Manufacturers (2020-2025)
4.2.3 Global Top 10 and Top 5 Companies by Artemisunate Revenue in 2024
4.3 Global Artemisunate Sales Price by Manufacturers (2020-2025)
4.4 Global Key Players of Artemisunate, Industry Ranking, 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Artemisunate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Artemisunate, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Artemisunate, Product Offered and Application
4.8 Global Key Manufacturers of Artemisunate, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Sales by Type
5.1.1 Global Artemisunate Historical Sales by Type (2020-2025)
5.1.2 Global Artemisunate Forecasted Sales by Type (2026-2031)
5.1.3 Global Artemisunate Sales Market Share by Type (2020-2031)
5.2 Global Revenue by Type
5.2.1 Global Artemisunate Historical Revenue by Type (2020-2025)
5.2.2 Global Artemisunate Forecasted Revenue by Type (2026-2031)
5.2.3 Global Artemisunate Revenue Market Share by Type (2020-2031)
5.3 Global Price by Type
5.3.1 Global Artemisunate Price by Type (2020-2025)
5.3.2 Global Artemisunate Price Forecast by Type (2026-2031)
6 Market Size by Application
6.1 Global Sales by Application
6.1.1 Global Artemisunate Historical Sales by Application (2020-2025)
6.1.2 Global Artemisunate Forecasted Sales by Application (2026-2031)
6.1.3 Global Artemisunate Sales Market Share by Application (2020-2031)
6.2 Global Revenue by Application
6.2.1 Global Artemisunate Historical Revenue by Application (2020-2025)
6.2.2 Global Artemisunate Forecasted Revenue by Application (2026-2031)
6.2.3 Global Artemisunate Revenue Market Share by Application (2020-2031)
6.3 Global Price by Application
6.3.1 Global Artemisunate Price by Application (2020-2025)
6.3.2 Global Artemisunate Price Forecast by Application (2026-2031)
7 US & Canada
7.1 US & Canada Market Size by Type
7.1.1 US & Canada Artemisunate Sales by Type (2020-2031)
7.1.2 US & Canada Artemisunate Revenue by Type (2020-2031)
7.2 US & Canada Market Size by Application
7.2.1 US & Canada Artemisunate Sales by Application (2020-2031)
7.2.2 US & Canada Artemisunate Revenue by Application (2020-2031)
7.3 US & Canada Market Size by Country
7.3.1 US & Canada Artemisunate Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 US & Canada Artemisunate Revenue by Country (2020-2031)
7.3.3 US & Canada Artemisunate Sales by Country (2020-2031)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Market Size by Type
8.1.1 Europe Artemisunate Sales by Type (2020-2031)
8.1.2 Europe Artemisunate Revenue by Type (2020-2031)
8.2 Europe Market Size by Application
8.2.1 Europe Artemisunate Sales by Application (2020-2031)
8.2.2 Europe Artemisunate Revenue by Application (2020-2031)
8.3 Europe Market Size by Country
8.3.1 Europe Artemisunate Revenue by Country: 2020 VS 2024 VS 2031
8.3.2 Europe Artemisunate Sales by Country (2020-2031)
8.3.3 Europe Artemisunate Revenue by Country (2020-2031)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Market Size by Type
9.1.1 China Artemisunate Sales by Type (2020-2031)
9.1.2 China Artemisunate Revenue by Type (2020-2031)
9.2 China Market Size by Application
9.2.1 China Artemisunate Sales by Application (2020-2031)
9.2.2 China Artemisunate Revenue by Application (2020-2031)
10 Asia (excluding China)
10.1 Asia Market Size by Type
10.1.1 Asia Artemisunate Sales by Type (2020-2031)
10.1.2 Asia Artemisunate Revenue by Type (2020-2031)
10.2 Asia Market Size by Application
10.2.1 Asia Artemisunate Sales by Application (2020-2031)
10.2.2 Asia Artemisunate Revenue by Application (2020-2031)
10.3 Asia Market Size by Region
10.3.1 Asia Artemisunate Revenue by Region: 2020 VS 2024 VS 2031
10.3.2 Asia Artemisunate Revenue by Region (2020-2031)
10.3.3 Asia Artemisunate Sales by Region (2020-2031)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Market Size by Type
11.1.1 Middle East, Africa and Latin America Artemisunate Sales by Type (2020-2031)
11.1.2 Middle East, Africa and Latin America Artemisunate Revenue by Type (2020-2031)
11.2 Middle East, Africa and Latin America Market Size by Application
11.2.1 Middle East, Africa and Latin America Artemisunate Sales by Application (2020-2031)
11.2.2 Middle East, Africa and Latin America Artemisunate Revenue by Application (2020-2031)
11.3 Middle East, Africa and Latin America Market Size by Country
11.3.1 Middle East, Africa and Latin America Artemisunate Revenue by Country: 2020 VS 2024 VS 2031
11.3.2 Middle East, Africa and Latin America Artemisunate Revenue by Country (2020-2031)
11.3.3 Middle East, Africa and Latin America Artemisunate Sales by Country (2020-2031)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Overview
12.1.3 Sanofi Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.4 Sanofi Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Sanofi Recent Developments
12.2 KPC Pharmaceuticals
12.2.1 KPC Pharmaceuticals Corporation Information
12.2.2 KPC Pharmaceuticals Overview
12.2.3 KPC Pharmaceuticals Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.4 KPC Pharmaceuticals Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 KPC Pharmaceuticals Recent Developments
12.3 Guangxi Xiancaotang Pharmaceutical
12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
12.3.2 Guangxi Xiancaotang Pharmaceutical Overview
12.3.3 Guangxi Xiancaotang Pharmaceutical Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.4 Guangxi Xiancaotang Pharmaceutical Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
12.4 Guilin Pharmaceutical
12.4.1 Guilin Pharmaceutical Corporation Information
12.4.2 Guilin Pharmaceutical Overview
12.4.3 Guilin Pharmaceutical Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.4 Guilin Pharmaceutical Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Guilin Pharmaceutical Recent Developments
12.5 Kerui Nanhai Pharmaceutical
12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
12.5.2 Kerui Nanhai Pharmaceutical Overview
12.5.3 Kerui Nanhai Pharmaceutical Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.4 Kerui Nanhai Pharmaceutical Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Kerui Nanhai Pharmaceutical Recent Developments
12.6 Shanghai Natural Bio-engineering Co
12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
12.6.2 Shanghai Natural Bio-engineering Co Overview
12.6.3 Shanghai Natural Bio-engineering Co Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.4 Shanghai Natural Bio-engineering Co Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Shanghai Natural Bio-engineering Co Recent Developments
12.7 Novanat Bioresource
12.7.1 Novanat Bioresource Corporation Information
12.7.2 Novanat Bioresource Overview
12.7.3 Novanat Bioresource Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.4 Novanat Bioresource Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Novanat Bioresource Recent Developments
12.8 Botanical Extracts EPZ Ltd
12.8.1 Botanical Extracts EPZ Ltd Corporation Information
12.8.2 Botanical Extracts EPZ Ltd Overview
12.8.3 Botanical Extracts EPZ Ltd Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.4 Botanical Extracts EPZ Ltd Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Botanical Extracts EPZ Ltd Recent Developments
12.9 CAT KHANH
12.9.1 CAT KHANH Corporation Information
12.9.2 CAT KHANH Overview
12.9.3 CAT KHANH Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.4 CAT KHANH Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 CAT KHANH Recent Developments
12.10 BIONEXX
12.10.1 BIONEXX Corporation Information
12.10.2 BIONEXX Overview
12.10.3 BIONEXX Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.4 BIONEXX Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 BIONEXX Recent Developments
12.11 Botanical Extracts EPZ
12.11.1 Botanical Extracts EPZ Corporation Information
12.11.2 Botanical Extracts EPZ Overview
12.11.3 Botanical Extracts EPZ Artemisunate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.4 Botanical Extracts EPZ Artemisunate Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Botanical Extracts EPZ Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Artemisunate Industry Chain Analysis
13.2 Artemisunate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Artemisunate Production Mode & Process
13.4 Artemisunate Sales and Marketing
13.4.1 Artemisunate Sales Channels
13.4.2 Artemisunate Distributors
13.5 Artemisunate Customers
14 Artemisunate Market Dynamics
14.1 Artemisunate Industry Trends
14.2 Artemisunate Market Drivers
14.3 Artemisunate Market Challenges
14.4 Artemisunate Market Restraints
15 Key Findings in the Global Artemisunate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Artemisunate Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Key Manufacturers of Pharmaceutical Grade
Table 3. Key Manufacturers of Industrial Grade
Table 4. Global Artemisunate Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 5. Global Artemisunate Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 6. Global Production by Region (2020-2031) & (MT)
Table 7. Global Production Market Share by Region (2020-2031)
Table 8. Global Artemisunate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 9. Global Revenue by Region (2020-2031) & (US$ Million)
Table 10. Global Revenue Market Share by Region (2020-2031)
Table 11. Global Artemisunate Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 12. Global Artemisunate Sales by Region (2020-2031) & (MT)
Table 13. Global Sales Market Share by Region (2020-2031)
Table 14. Global Artemisunate Sales by Manufacturers (2020-2025) & (MT)
Table 15. Global Artemisunate Sales Share by Manufacturers (2020-2025)
Table 16. Global Artemisunate Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 17. Global Artemisunate Revenue Market Share by Manufacturers (2020-2025)
Table 18. Artemisunate Price by Manufacturers (2020-2025) & (USD/MT)
Table 19. Global Key Players of Artemisunate, Industry Ranking, 2023 VS 2024
Table 20. Global Artemisunate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Artemisunate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisunate as of 2024)
Table 22. Global Key Manufacturers of Artemisunate, Manufacturing Base Distribution and Headquarters
Table 23. Global Key Manufacturers of Artemisunate, Product Offered and Application
Table 24. Global Key Manufacturers of Artemisunate, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Artemisunate Sales by Type (2020-2025) & (MT)
Table 27. Global Artemisunate Sales by Type (2026-2031) & (MT)
Table 28. Global Sales Share by Type (2020-2031)
Table 29. Global Artemisunate Revenue by Type (2020-2025) & (US$ Million)
Table 30. Global Artemisunate Revenue by Type (2026-2031) & (US$ Million)
Table 31. Global Revenue Share by Type (2020-2031)
Table 32. Artemisunate Price by Type (2020-2025) & (USD/MT)
Table 33. Global Artemisunate Price Forecast by Type (2026-2031) & (USD/MT)
Table 34. Global Artemisunate Sales by Application (2020-2025) & (MT)
Table 35. Global Artemisunate Sales by Application (2026-2031) & (MT)
Table 36. Global Sales Share by Application (2020-2031)
Table 37. Global Artemisunate Revenue by Application (2020-2025) & (US$ Million)
Table 38. Global Artemisunate Revenue by Application (2026-2031) & (US$ Million)
Table 39. Global Revenue Share by Application (2020-2031)
Table 40. Artemisunate Price by Application (2020-2025) & (USD/MT)
Table 41. Global Artemisunate Price Forecast by Application (2026-2031) & (USD/MT)
Table 42. US & Canada Sales by Type (2020-2031) & (MT)
Table 43. US & Canada Revenue by Type (2020-2031) & (US$ Million)
Table 44. US & Canada Sales by Application (2020-2031) & (MT)
Table 45. US & Canada Revenue by Application (2020-2031) & (US$ Million)
Table 46. US & Canada Artemisunate Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. US & Canada Revenue by Country (2020-2031) & (US$ Million)
Table 48. US & Canada Sales by Country (2020-2031) & (MT)
Table 49. Europe Sales by Type (2020-2031) & (MT)
Table 50. Europe Revenue by Type (2020-2031) & (US$ Million)
Table 51. Europe Sales by Application (2020-2031) & (MT)
Table 52. Europe Revenue by Application (2020-2031) & (US$ Million)
Table 53. Europe Artemisunate Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 54. Europe Sales by Country (2020-2031) & (MT)
Table 55. Europe Revenue by Country (2020-2031) & (US$ Million)
Table 56. China Sales by Type (2020-2031) & (MT)
Table 57. China Revenue by Type (2020-2031) & (US$ Million)
Table 58. China Sales by Application (2020-2031) & (MT)
Table 59. China Revenue by Application (2020-2031) & (US$ Million)
Table 60. Asia Sales by Type (2020-2031) & (MT)
Table 61. Asia Revenue by Type (2020-2031) & (US$ Million)
Table 62. Asia Sales by Application (2020-2031) & (MT)
Table 63. Asia Revenue by Application (2020-2031) & (US$ Million)
Table 64. Asia Artemisunate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 65. Asia Revenue by Region (2020-2031) & (US$ Million)
Table 66. Asia Sales by Region (2020-2031) & (MT)
Table 67. Middle East, Africa and Latin America Sales by Type (2020-2031) & (MT)
Table 68. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
Table 69. Middle East, Africa and Latin America Sales by Application (2020-2031) & (MT)
Table 70. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
Table 71. Middle East, Africa and Latin America Artemisunate Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 72. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
Table 73. Middle East, Africa and Latin America Sales by Country (2020-2031) & (MT)
Table 74. Sanofi Corporation Information
Table 75. Sanofi Description and Major Businesses
Table 76. Sanofi Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 77. Sanofi Product Model Numbers, Pictures, Descriptions and Specifications
Table 78. Sanofi Recent Developments
Table 79. KPC Pharmaceuticals Corporation Information
Table 80. KPC Pharmaceuticals Description and Major Businesses
Table 81. KPC Pharmaceuticals Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. KPC Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 83. KPC Pharmaceuticals Recent Developments
Table 84. Guangxi Xiancaotang Pharmaceutical Corporation Information
Table 85. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses
Table 86. Guangxi Xiancaotang Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Guangxi Xiancaotang Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 88. Guangxi Xiancaotang Pharmaceutical Recent Developments
Table 89. Guilin Pharmaceutical Corporation Information
Table 90. Guilin Pharmaceutical Description and Major Businesses
Table 91. Guilin Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. Guilin Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 93. Guilin Pharmaceutical Recent Developments
Table 94. Kerui Nanhai Pharmaceutical Corporation Information
Table 95. Kerui Nanhai Pharmaceutical Description and Major Businesses
Table 96. Kerui Nanhai Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Kerui Nanhai Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 98. Kerui Nanhai Pharmaceutical Recent Developments
Table 99. Shanghai Natural Bio-engineering Co Corporation Information
Table 100. Shanghai Natural Bio-engineering Co Description and Major Businesses
Table 101. Shanghai Natural Bio-engineering Co Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Shanghai Natural Bio-engineering Co Product Model Numbers, Pictures, Descriptions and Specifications
Table 103. Shanghai Natural Bio-engineering Co Recent Developments
Table 104. Novanat Bioresource Corporation Information
Table 105. Novanat Bioresource Description and Major Businesses
Table 106. Novanat Bioresource Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Novanat Bioresource Product Model Numbers, Pictures, Descriptions and Specifications
Table 108. Novanat Bioresource Recent Developments
Table 109. Botanical Extracts EPZ Ltd Corporation Information
Table 110. Botanical Extracts EPZ Ltd Description and Major Businesses
Table 111. Botanical Extracts EPZ Ltd Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Botanical Extracts EPZ Ltd Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Botanical Extracts EPZ Ltd Recent Developments
Table 114. CAT KHANH Corporation Information
Table 115. CAT KHANH Description and Major Businesses
Table 116. CAT KHANH Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. CAT KHANH Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. CAT KHANH Recent Developments
Table 119. BIONEXX Corporation Information
Table 120. BIONEXX Description and Major Businesses
Table 121. BIONEXX Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. BIONEXX Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. BIONEXX Recent Developments
Table 124. Botanical Extracts EPZ Corporation Information
Table 125. Botanical Extracts EPZ Description and Major Businesses
Table 126. Botanical Extracts EPZ Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Botanical Extracts EPZ Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Botanical Extracts EPZ Recent Developments
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Distributors List
Table 132. Customers List
Table 133. Market Trends
Table 134. Market Drivers
Table 135. Market Challenges
Table 136. Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Artemisunate Product Picture
Figure 2. Global Artemisunate Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Artemisunate Market Share by Type: 2024 & 2031
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Industrial Grade Product Picture
Figure 6. Global Artemisunate Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Global Artemisunate Market Share by Application in 2024 & 2031
Figure 8. Malaria Treatment
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Artemisunate Report Years Considered
Figure 12. Global Artemisunate Capacity, Production and Utilization (2020-2031) & (MT)
Figure 13. Global Artemisunate Production by Region (2020 – 2031) (MT)
Figure 14. Global Artemisunate Production Market Share by Region in Percentage: 2024 Versus 2031
Figure 15. Global Artemisunate Production Market Share by Region (2020-2031)
Figure 16. Artemisunate Production Growth Rate in North America (2020-2031) & (MT)
Figure 17. Artemisunate Production Growth Rate in Europe (2020-2031) & (MT)
Figure 18. Artemisunate Production Growth Rate in China (2020-2031) & (MT)
Figure 19. Artemisunate Production Growth Rate in Japan (2020-2031) & (MT)
Figure 20. Global Artemisunate Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 22. Global Artemisunate Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 23. Global Artemisunate Revenue Market Share by Region in Percentage: 2024 Versus 2031
Figure 24. Global Artemisunate Revenue Market Share by Region (2020-2031)
Figure 25. Global Artemisunate Sales (2020-2031) & (MT)
Figure 26. Global Artemisunate Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Figure 27. Global Artemisunate Sales Market Share by Region (2020-2031)
Figure 28. US & Canada Artemisunate Sales YoY (2020-2031) & (MT)
Figure 29. US & Canada Artemisunate Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Artemisunate Sales YoY (2020-2031) & (MT)
Figure 31. Europe Artemisunate Revenue YoY (2020-2031) & (US$ Million)
Figure 32. China Artemisunate Sales YoY (2020-2031) & (MT)
Figure 33. China Artemisunate Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Asia (excluding China) Artemisunate Sales YoY (2020-2031) & (MT)
Figure 35. Asia (excluding China) Artemisunate Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Middle East, Africa and Latin America Artemisunate Sales YoY (2020-2031) & (MT)
Figure 37. Middle East, Africa and Latin America Artemisunate Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Global Artemisunate Sales Share by Manufacturers (2024)
Figure 39. The Artemisunate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 40. Global Artemisunate Revenue Share by Manufacturers (2024)
Figure 41. The Top 5 and 10 Largest Manufacturers of Artemisunate in the World: Market Share by Artemisunate Revenue in 2024
Figure 42. Global Artemisunate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 43. Global Artemisunate Sales Market Share by Type (2020-2031)
Figure 44. Global Artemisunate Revenue Market Share by Type (2020-2031)
Figure 45. Global Artemisunate Sales Market Share by Application (2020-2031)
Figure 46. Global Artemisunate Revenue Market Share by Application (2020-2031)
Figure 47. US & Canada Artemisunate Sales Market Share by Type (2020-2031)
Figure 48. US & Canada Artemisunate Revenue Market Share by Type (2020-2031)
Figure 49. US & Canada Artemisunate Sales Market Share by Application (2020-2031)
Figure 50. US & Canada Artemisunate Revenue Market Share by Application (2020-2031)
Figure 51. US & Canada Artemisunate Revenue Share by Country (2020-2031)
Figure 52. US & Canada Artemisunate Sales Share by Country (2020-2031)
Figure 53. US Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 54. Canada Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 55. Europe Artemisunate Sales Market Share by Type (2020-2031)
Figure 56. Europe Artemisunate Revenue Market Share by Type (2020-2031)
Figure 57. Europe Artemisunate Sales Market Share by Application (2020-2031)
Figure 58. Europe Artemisunate Revenue Market Share by Application (2020-2031)
Figure 59. Europe Artemisunate Sales Share by Country (2020-2031)
Figure 60. Europe Artemisunate Revenue Share by Country (2020-2031)
Figure 61. Germany Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 62. France Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 63. U.K. Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 64. Italy Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 65. Russia Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 66. China Artemisunate Sales Market Share by Type (2020-2031)
Figure 67. China Artemisunate Revenue Market Share by Type (2020-2031)
Figure 68. China Artemisunate Sales Market Share by Application (2020-2031)
Figure 69. China Artemisunate Revenue Market Share by Application (2020-2031)
Figure 70. Asia Artemisunate Sales Market Share by Type (2020-2031)
Figure 71. Asia Artemisunate Revenue Market Share by Type (2020-2031)
Figure 72. Asia Artemisunate Sales Market Share by Application (2020-2031)
Figure 73. Asia Artemisunate Revenue Market Share by Application (2020-2031)
Figure 74. Asia Artemisunate Revenue Share by Region (2020-2031)
Figure 75. Asia Artemisunate Sales Share by Region (2020-2031)
Figure 76. Japan Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 77. South Korea Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 78. China Taiwan Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 79. Southeast Asia Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 80. India Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Artemisunate Sales Market Share by Type (2020-2031)
Figure 82. Middle East, Africa and Latin America Artemisunate Revenue Market Share by Type (2020-2031)
Figure 83. Middle East, Africa and Latin America Artemisunate Sales Market Share by Application (2020-2031)
Figure 84. Middle East, Africa and Latin America Artemisunate Revenue Market Share by Application (2020-2031)
Figure 85. Middle East, Africa and Latin America Artemisunate Revenue Share by Country (2020-2031)
Figure 86. Middle East, Africa and Latin America Artemisunate Sales Share by Country (2020-2031)
Figure 87. Brazil Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 88. Mexico Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 89. Turkey Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 90. Israel Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 91. GCC Countries Artemisunate Revenue (2020-2031) & (US$ Million)
Figure 92. Value Chain
Figure 93. Artemisunate Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Artemisunate market?
The top companies in the global Artemisunate market are Sanofi、KPC Pharmaceuticals、Guangxi Xiancaotang Pharmaceutical.
Related Reports
Global Artemisunate Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artemisunate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 96
USD 4250.00
(Single User License)
Global Artemisunate Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Artemisunate market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 152
USD 4900.00
(Single User License)
Artemisunate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artemisunate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 112
USD 3950.00
(Single User License)
Global Artemisunate Market Research Report 2026
The global Artemisunate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 145
USD 2900.00
(Single User License)
Global Artemisunate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artemisunate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 162
USD 4900.00
(Single User License)
Artemisunate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artemisunate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 118
USD 3950.00
(Single User License)
Global Artemisunate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artemisunate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 94
USD 4250.00
(Single User License)
Global Artemisunate Market Research Report 2025
The global market for Artemisunate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-06-04
Pages: 96
USD 2900.00
(Single User License)
Artemisunate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artemisunate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 92
USD 3950.00
(Single User License)
Artemisunate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Artemisunate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 104
USD 3950.00
(Single User License)
Global Artemisunate Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artemisunate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 96
USD 4250.00 (Single User License)Global Artemisunate Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Artemisunate market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 152
USD 4900.00 (Single User License)Artemisunate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artemisunate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 112
USD 3950.00 (Single User License)Global Artemisunate Market Research Report 2026
The global Artemisunate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 145
USD 2900.00 (Single User License)Global Artemisunate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artemisunate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 162
USD 4900.00 (Single User License)Artemisunate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artemisunate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 118
USD 3950.00 (Single User License)Global Artemisunate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artemisunate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 94
USD 4250.00 (Single User License)Global Artemisunate Market Research Report 2025
The global market for Artemisunate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-06-04
Pages: 96
USD 2900.00 (Single User License)Artemisunate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artemisunate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 92
USD 3950.00 (Single User License)Artemisunate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Artemisunate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 104
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now